Diabetes blocks the cardioprotective effects of sevoflurane postconditioning by impairing Nrf2/Brg1/HO-1 signaling
- 1 May 2016
- journal article
- Published by Elsevier BV in European Journal of Pharmacology
- Vol. 779, 111-121
- https://doi.org/10.1016/j.ejphar.2016.03.018
Abstract
No abstract availableKeywords
Funding Information
- National Natural Science Foundation of China (Nos. 81200609 and 81370112)
- GRF
This publication has 47 references indexed in Scilit:
- Nrf2-regulated antioxidant response is activated by protein kinase C in postconditioned rat heartsFree Radical Biology & Medicine, 2014
- Prevention by sulforaphane of diabetic cardiomyopathy is associated with up-regulation of Nrf2 expression and transcription activationJournal of Molecular and Cellular Cardiology, 2013
- Genetic and Pharmacologic Hydrogen Sulfide Therapy Attenuates Ischemia-Induced Heart Failure in MiceCirculation, 2010
- Hydrogen Sulfide Mediates Cardioprotection Through Nrf2 SignalingCirculation Research, 2009
- Intensive versus conventional insulin therapy: A randomized controlled trial in medical and surgical critically ill patients*Critical Care Medicine, 2008
- Acute Metformin Therapy Confers Cardioprotection Against Myocardial Infarction Via AMPK-eNOS–Mediated SignalingDiabetes, 2008
- Infarct size, ejection fraction, and mortality in diabetic patients with acute myocardial infarction treated with thrombolytic therapyAmerican Heart Journal, 2007
- Cardioprotection Via Activation of Protein Kinase C-δ Depends on Modulation of the Reverse Mode of the Na + /Ca 2+ ExchangerCirculation, 2006
- Cyclooxygenase-2 Mediates Ischemic, Anesthetic, and Pharmacologic Preconditioning In VivoAnesthesiology, 2004
- Heme oxygenase‐1‐derived carbon monoxide protects hearts from transplant‐associated ischemia reperfusion injuryThe FASEB Journal, 2004